Effects of fish oil on lipid profile and other metabolic outcomes in HIV-infected patients on antiretroviral therapy: A randomized placebo-controlled trial

International Journal of STD and AIDS

Volumn 25, Issue 2, 2014, Pages 96-104

  Oliveira, Julicristie M ^a   Rondó, Patrícia HC ^b   Yudkin, John S ^c   Souza, José MP ^b   Pereira, Tatiane N ^b   Catalani, Andrea W ^b   Picone, Camila M ^b   Segurado, Aluisio AC ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

AIDS; fish oils; HIV; hypertriglyceridaemia; insulin resistance; lipid profile; lipodystrophy; low density lipoprotein cholesterol; metabolic syndrome; omega 3 fatty acids

Indexed keywords

ANTIRETROVIRUS AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; PLACEBO; SOYBEAN OIL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

AIDS; FISH OILS; HIV; HYPERTRIGLYCERIDAEMIA; INSULIN RESISTANCE; LIPID PROFILE; LIPODYSTROPHY; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; OMEGA-3 FATTY ACIDS;

ADULT; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY FAT DISTRIBUTION; BODY MASS INDEX; BRAZIL; FEMALE; FISH OILS; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; SOYBEAN OIL; TREATMENT OUTCOME;

EID: 84893462296     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413513748     Document Type: Article

References (26)

1. Friis-Møller N,Weber R,Reiss P, et al.Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.AIDS. 2003;17:1179-1193.
2. Grunfeld C.Dyslipidemia and its treatment in HIV infection.Top HIV Med. 2010;18:112-108.
3. Oliveira JM,Rondó PHC.Omega-3 fatty acids and hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: systematic review and meta-analysis.HIV Clin Trials. 2011;12:268-274.
4. Jacobson TA.Role of n-3 fatty acids in the treatment of hypertriglyceridaemia and cardiovascular disease.Am J Clin Nutr. 2008;87:1981-1990.
5. Baril JG,Kovacs CM,Trottier S, et al.Effectiveness and tolerability of oral administration of low-dose salmon oil to HIV patients with HAART-associated dyslipidemia.HIV Clin Trials. 2007;8:400-411.
6. Rudkowska I.Fish oils for cardiovascular disease: impact on diabetes.Maturitas. 2010;67:25-28.
7. Florindo AA,Latorre MRD,Santos ECM, et al.Validity and reliability of the Baecke questionnaire for the evaluation of habitual physical activity among people living HIV/AIDS.Cad Saude Publica. 2006;3:535-541.
8. Baecke JA,Burema J,Frijters JE.A short questionnaire for the measurement of habitual physical activity in epidemiological studies.Am J Clin Nutr. 1982;36:936-942.
9. Conway JM,Ingwersen LA,Vinyard BT, et al.Effectiveness of the USDA's five-step multiple-pass method to assess food intake in obese and nonobese women.Am J Clin Nutr. 2003;77:1171-1178.
10. Conway JM,Ingwersen LA,Moshfegh AJ.Accuracy of dietary recall using the USDA five-step multiple-pass method in men: an observational validation study.J Am Diet Assoc. 2004;104:595-603.
11. Departamento de Informática em Saúde. Universidade Federal de São Paulo, 2005; 2005:.
12. US Department of Agriculture, Agricultural Research Service. 2008. USDA National Nutrient Database for Standard Reference, Release 21. Nutrient Data Laboratory Home Page, http://www.ars.usda.gov/ba/bhnrc/ndl (accessed 3 March 2009).
13. Tabela brasileira de composição de alimentos (Versão II). 2 ed. Campinas: NEPA-UNICAMP, 2006.Campinas: NEPA-UNICAMP; 2006:.
14. Hagiwara KStandard tables of food composition in Japan. 5 ed. Tokyo: National Institute Health and Nutrition, 1995.Tokyo: National Institute Health and Nutrition; 1995:.
15. Wallace TM,Levy JC,Matthews DR.Use and abuse of HOMA modeling.Diab Care. 2004;27:1487-1495.
16. Eslick GD.Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis.Int J Cardiol. 2009;136:4-16.
17. Khovidhunkit W,Kim MS,Memon RA, et al.Thematic review series: the pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host.J Lipid Res. 2004;45:1169-1196.
18. Mello AP,Silva IT,Oliveira AS, et al.Electronegative low-density lipoprotein is associated with dense low-density lipoprotein in subjects with different levels of cardiovascular risk.Lipids. 2010;45:619-625.
19. Balk E,Chung M,Lichtenstein A, et alEvidence report/technology assessment No. 93 (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022). AHRQ Publication No. 04-E010-2. Rockville, MD: Agency for Healthcare Research and Quality; March 2004:.
20. Wohl DA,Tien HC,Busby M, et al.Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counselling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.Clin Infect Dis. 2005;45:1498-1450.
21. Bays HE,Maki KC,Doyle RT, et al.The effect of prescription omega-3 fatty acids on body weight after 8 to 16 weeks of treatment for very high triglyceride levels.Postgrad Med. 2009;121:145-150.
22. Stradling C,Chen Y-F,Russell T, et al.The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis.PLoS ONE. 2012;7:e38121-e38121.
23. Peters BS,Wierzbicki AS,Moyle G, et al.The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.Clin Ther. 2012;34:67-76.
24. Bays HE,Ballantyne CM,Kastelein JJ, et al.Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, placebo-controlled, Randomized, double-blind, 12-week study with an open-label Extension [MARINE] trial).Am J Cardiol. 2011;108:682-690.
25. de Lorgeril M,Salen P,Defaye P, et al.Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?.BMC Med. 2013;11:1-13.
26. Pisprasert V,Ingram KH,Lopez-Davila MF, et al.Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.Diab Care. 2013;36:845-853.